Axel Schambach

发表

Assessing genotoxicity of lenti- and gammaretroviral vectors in vitro

Christopher Baum, Ute Modlich, S Knoss, 2009 .

Artemis and ligase 4 are dispensable for the generation of human induced pluripotent stem cells

Christopher Baum, T Matzig, Axel Schambach, 2012 .

State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations.

Zeger Debyser, Rik Gijsbers, Jaan Toelen, 2009, Current gene therapy.

Large-Scale Hematopoietic Differentiation of Human Induced Pluripotent Stem Cells Provides Granulocytes or Macrophages for Cell Replacement Therapies

Gesine Hansen, Axel Schambach, Nico Lachmann, 2015, Stem cell reports.

Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity

Michael Rothe, Christof von Kalle, Raffaele Fronza, 2014, Science Translational Medicine.

Engineering CAR-T Cells for Improved Function Against Solid Tumors

Axel Schambach, A. Schambach, Michael A. Morgan, 2018, Front. Immunol..

and insertional genotoxicity Cell culture assays reveal the importance of retroviral vector design for

Christof von Kalle, Christopher Baum, Ute Modlich, 2006 .

miR-99a/100∼125b tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGFβ and Wnt signaling

Axel Schambach, Ying Xie, A. Schambach, 2014, Genes & development.

Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors

Axel Schambach, Holm Zaehres, Jack Antel, 2017, Proceedings of the National Academy of Sciences.

Preparation of bioactive soluble human leukemia inhibitory factor from recombinant Escherichia coli using thioredoxin as fusion partner.

Thomas Scheper, Frank Stahl, Axel Schambach, 2010, Protein expression and purification.

Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming.

Christopher Baum, Axel Schambach, Timm Schroeder, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG)

Erdmann Rapp, Udo Reichl, Samanta Cajic, 2016, Molecular & Cellular Proteomics.

Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity

Axel Schambach, Frank Buchholz, Adam Grundhoff, 2016, Nature Biotechnology.

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

Christopher Baum, David A. Williams, Gregory Hopkins, 2014, The New England journal of medicine.